Results
1 -
10 of
24The serotonergic system in motor and non-motor manifestations of Parkinsonu2019s disease, Experimental Brain Research The Serotonergic System in Levodopa-Induced Dyskinesia, Levodopa-Induced Dyskinesia in Parkinson's Disease Serotonergic targets for the treatment of l-DOPA-induced dyskinesia, Journal of Neural Transmission The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective, Journal of Neural Transmission Pharmacological treatment of Parkinsonu2019s disease: life beyond dopamine D2/D3 receptors?, Journal of Neural Transmission Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinsonu2019s disease, Journal of Neural Transmission Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile, Journal of Neural Transmission Aktuelle pr??klinische Befunde zu Anti-Parkinson-Mitteln, Der Nervenarzt Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats, Psychopharmacology